Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE\ATORVASTATIN Cause Bronchitis? 6 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Bronchitis have been filed in association with AMLODIPINE\ATORVASTATIN. This represents 0.9% of all adverse event reports for AMLODIPINE\ATORVASTATIN.

6
Reports of Bronchitis with AMLODIPINE\ATORVASTATIN
0.9%
of all AMLODIPINE\ATORVASTATIN reports
0
Deaths
1
Hospitalizations

How Dangerous Is Bronchitis From AMLODIPINE\ATORVASTATIN?

Of the 6 reports, 1 (16.7%) required hospitalization.

Is Bronchitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE\ATORVASTATIN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE\ATORVASTATIN Cause?

Malaise (55) Type 2 diabetes mellitus (38) Drug ineffective (31) Drug hypersensitivity (30) Death (28) Dizziness (23) Pain (23) Hypertension (21) Hypoacusis (21) Memory impairment (21)

What Other Drugs Cause Bronchitis?

ADALIMUMAB (3,880) ETANERCEPT (3,799) METHOTREXATE (2,233) TOFACITINIB (2,036) LENALIDOMIDE (1,998) OMALIZUMAB (1,785) HUMAN IMMUNOGLOBULIN G (1,637) ALBUTEROL (1,525) ABATACEPT (1,519) PREDNISONE (1,496)

Which AMLODIPINE\ATORVASTATIN Alternatives Have Lower Bronchitis Risk?

AMLODIPINE\ATORVASTATIN vs AMLODIPINE\BENAZEPRIL AMLODIPINE\ATORVASTATIN vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE\ATORVASTATIN vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL AMLODIPINE\ATORVASTATIN vs AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN AMLODIPINE\ATORVASTATIN vs AMLODIPINE\INDAPAMIDE\PERINDOPRIL

Related Pages

AMLODIPINE\ATORVASTATIN Full Profile All Bronchitis Reports All Drugs Causing Bronchitis AMLODIPINE\ATORVASTATIN Demographics